All Type of News
Boehringer Ingelheim Introduces COPD Treatment in Domestic Market
Boehringer Ingelheim Korea and Pfizer Korea announced that Spiriva HandiHaler (tiotropium bromide), for the treatment of COPD (Chronic Obstructive Pulmonary Disease), will be available in the domestic market starting ...
KFDA Issues Revised Approval Specifications on Neurontin
The Korea Food and Drug Administration has recently issued the revised market approval specifications on Pfizer Korea's Neurontin (active ingredient: gabapentin) products.
Currently, Neurontin is available in the d...
Choongwae Enters Competitive Hyperlipidemia Treatment Market
Choongwae Pharmaceutical enters the domestic hyperlipidemia treatment market valued over 100 billion won by obtaining the market approval for Livalo, an original drug co-developed by Japan's Kowa Yakuhin and Nissan Ch...
MSD Korea's Cholesterol Absorption Inhibitor Now Available
Six months after obtaining a market approval by the Korea Food and Drug Administration (KFDA), MSD Korea officially announced that Ezetrol, a cholesterol absorption inhibitor, is now available in the domestic market. ...
Proper Measurement Device Needed for Bulk Pharmaceutical Products
The Korea Pharmaceutical Association (KPA) plans to make a request to the pharmaceutical manufacturers on including proper measurement devices for the prescription-based syrup medications, based on an increasing numbe...
New GMP Guideline for Biopharmaceutical and Biotech-Based Products
The Korea Food and Drug Administration (KFDA) has recently completed a new administrative guideline for GMP (Good Manufacturing Practice) evaluation as specific to the domestic manufacturers of biopharmaceutical produ...
Government and Drug Makers Face with Seven Lawsuits over PPA Incident
The pharmaceutical industry is making a close observation on the on-going litigation process involving last year's ban on the production and sale of cold remedies containing phenylpropanolamine (PPA), which led to sub...
Medical Community Opposes Pharmaceutical Small Packaging Requirement
The Korea Medical Association (KMA) has recently made a request to eradicate the proposed small packaging requirement on the pharmaceutical products, which is currently pending for review by the Regulatory Reform Comm...
Kwangdong Implements Total Productive Maintenance Program
Kwangdong Pharmaceutical has implemented a production plant and equipment maintenance concept known as the TPM (Total Productive Maintenance) program, to lead a company-wide recognition and participation towards impro...
DongKoo Achieves $3 Million USD Export Agreement to Taiwan
DongKoo Pharmaceutical announced that it has recently made a $3 million USD export agreement to Taiwan for the current year, surpassing last year's level of $1 million USD from exports to over ten countries worldwide....
